US OptionsDetailed Quotes
KZIA241115C1000
- 0.05
- 0.000.00%
15min DelayTrading Oct 22 09:30 ET
0.00High0.00Low
0.00Open0.05Pre Close0 Volume110 Open Interest1.00Strike Price0.00Turnover262.96%IV86.83%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier22DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.2922Delta0.9340Gamma11.25Leverage Ratio-0.0029Theta0.0001Rho3.29Eff Leverage0.0005Vega
Kazia Therapeutics Newsroom
Kazia Therapeutics Analyst Ratings
Buy Rating on Kazia Therapeutics Backed by Promising GBM Study Results and Strong Financial Valuation
HC Wainwright & Co. Upgrades Kazia Therapeutics to Buy, Announces $2 Price Target
No More